These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 6366151)

  • 1. Prognostic significance of erythrocyte sedimentation rate in clinical stages I-II of Hodgkin's disease.
    Tubiana M; Henry-Amar M; Burgers MV; van der Werf-Messing B; Hayat M
    J Clin Oncol; 1984 Mar; 2(3):194-200. PubMed ID: 6366151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolution of erythrocyte sedimentation rate as predictor of early relapse in posttherapy early-stage Hodgkin's disease.
    Friedman S; Henry-Amar M; Cosset JM; Carde P; Hayat M; Dupouy N; Tubiana M
    J Clin Oncol; 1988 Apr; 6(4):596-602. PubMed ID: 3357004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythrocyte sedimentation rate predicts early relapse and survival in early-stage Hodgkin disease. The EORTC Lymphoma Cooperative Group.
    Henry-Amar M; Friedman S; Hayat M; Somers R; Meerwaldt JH; Carde P; Burgers JM; Thomas J; Monconduit M; Noordijk EM
    Ann Intern Med; 1991 Mar; 114(5):361-5. PubMed ID: 1992877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical significance of erythrocyte sedimentation rate, C-reactive protein and serum lactate dehydrogenase levels in the diagnosis, prognosis and treatment monitoring of children suffering from cancer].
    Bień E; Balcerska A
    Med Wieku Rozwoj; 2004; 8(4 Pt 2):1081-9. PubMed ID: 15951603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current trend in the treatment of Hodgkin's disease.
    Tubiana M; Amiel JL; Hayat M; Henry-Amar M; Cosset JM; Droz JP; Carde P
    Radiat Med; 1983; 1(3):221-9. PubMed ID: 6390537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The contribution of clinical trials to the treatment of patients with early stages of Hodgkin's disease.
    Tubiana M; Cosset JM; Carde P; Henry-Amar M; Hayat M; Amiel JL
    Drugs Exp Clin Res; 1986; 12(1-3):105-12. PubMed ID: 3732047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New prognostic score based on treatment outcome of patients with relapsed Hodgkin's lymphoma registered in the database of the German Hodgkin's lymphoma study group.
    Josting A; Franklin J; May M; Koch P; Beykirch MK; Heinz J; Rudolph C; Diehl V; Engert A
    J Clin Oncol; 2002 Jan; 20(1):221-30. PubMed ID: 11773173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum soluble interleukin-2 receptor, beta2-microglobulin, lactate dehydrogenase and erythrocyte sedimentation rate in children with Hodgkin's lymphoma.
    Bien E; Balcerska A
    Scand J Immunol; 2009 Nov; 70(5):490-500. PubMed ID: 19874554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Late relapse in early-stage Hodgkin's disease patients enrolled on European Organization for Research and Treatment of Cancer protocols.
    Bodis S; Henry-Amar M; Bosq J; Burgers JM; Mellink WA; Dietrich PY; Dupouy N; Noordijk EM; Raemaekers JM; Thomas J
    J Clin Oncol; 1993 Feb; 11(2):225-32. PubMed ID: 8426198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is higher income and educational status associated with poorer outcome in patients with Hodgkin's disease?
    Holzner B; Fischhofer M; Kemmler G; Kopp M; Sperner-Unterweger B; Krugmann J; Dirnhofer S; Greil R
    Eur J Haematol; 2004 Nov; 73(5):318-24. PubMed ID: 15458510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A retrospective analysis of the treatment results in Hodgkin's disease in a radiotherapy clinic].
    Mjaaland I; Ganser D; Freitag EM; Bohndorf W
    Strahlenther Onkol; 1994 Sep; 170(9):516-23. PubMed ID: 7524173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic markers of disease activity in Hodgkin's disease.
    Martinow AJ; Yuen K; Cooper IA; Matthews JP; Juneja S; Wolf M; Januszewicz H; Prince HM
    Leuk Lymphoma; 1998 Apr; 29(3-4):383-9. PubMed ID: 9684935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Grades of nodular sclerosis (NSI-NSII) in Hodgkin's disease. Are they of independent prognostic value?
    Wijlhuizen TJ; Vrints LW; Jairam R; Breed WP; Wijnen JT; Bosch LJ; Crommelin MA; van Dam FE; de Koning J; Verhagen-Teulings M
    Cancer; 1989 Mar; 63(6):1150-3. PubMed ID: 2917317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the prognostic meaning of C-reactive protein (CRP) in children and adolescents with classical Hodgkin's lymphoma (HL).
    Haase R; Vilser C; Mauz-Körholz C; Hasenclever D; Kluge R; Ruschke K; Borkhardt A; Seeger K; Lehrnbecher T; Kulozik A; Rößler J; Burdach S; Jürgens H; Körholz D
    Klin Padiatr; 2012 Oct; 224(6):377-81. PubMed ID: 23047832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumour burden in early stage Hodgkin's disease: the single most important prognostic factor for outcome after radiotherapy.
    Specht L; Nordentoft AM; Cold S; Clausen NT; Nissen NI
    Br J Cancer; 1987 May; 55(5):535-9. PubMed ID: 3300762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An analysis of prognostic factors in early stage Hodgkin's disease.
    Horwich A; Easton D; Nogueira-Costa R; Liew KH; Colman M; Peckham MJ
    Radiother Oncol; 1986 Oct; 7(2):95-106. PubMed ID: 3786824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone marrow involvement in Hodgkin's disease: an analysis of 135 consecutive cases. German Hodgkin's Lymphoma Study Group.
    Munker R; Hasenclever D; Brosteanu O; Hiller E; Diehl V
    J Clin Oncol; 1995 Feb; 13(2):403-9. PubMed ID: 7844601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical relevance of plasma viscosity in Hodgkin's disease.
    Akhtar N; Thompson J; Durrant ST; Angel CA; Lauder I; Wood JK
    Clin Lab Haematol; 1991; 13(1):1-8. PubMed ID: 2060259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival after recurrence: prognostic factors and spread patterns in clinical stages I and II of Hodgkin's disease.
    Tubiana M; van der Werf-Messing B; Laugier A; Hayat M; Henry-Amar M; Attie E; Leroy T
    Natl Cancer Inst Monogr; 1973 May; 36():513-30. PubMed ID: 4744607
    [No Abstract]   [Full Text] [Related]  

  • 20. Value of serum copper levels and erythrocyte sedimentation rates as indicators of disease activity in children with Hodgkin's disease.
    Wilimas J; Thompson E; Smith KL
    Cancer; 1978 Oct; 42(4):1929-35. PubMed ID: 709539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.